Prior studies have suggested that CA125 may facilitate peritoneal metastasis via binding to MSLN in ovarian cancer [28, 29] and the CA125-MSLN interaction is associated with increased invasion and worse prognosis in pancreatic cancer [30, 31]. This evidence concerns the gene MUC16 and ovarian carcinoma.